Skip to main content
OpenTrials

Clinical trial condition

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

Explore clinical trials studying Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities. Study availability and eligibility vary by location and protocol.

113 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities trial results

Completed

Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia

NCT00085124

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +6 more
Locations
  • Cancer and Leukemia Group B Chicago, Illinois, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy

NCT01869114

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +17 more
Locations
  • Jefferson Health NJ Division (Kennedy Hospital) Sewell, New Jersey, United States
  • Abington Hospital - Jefferson Health Abington, Pennsylvania, United States
  • Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Jefferson Health, Aria Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02085408

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 269 locations
View Trial Details

Related conditions